Business Standard

Monday, December 23, 2024 | 11:50 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

What ails India's battle against TB: Patients not completing treatment

While the number of TB cases fell from 2015 to 2016, the number of MDR TB cases increased by 13 per cent

Tuberculosis, Tuberculosis in india, tb
Premium

Tuberculosis. Photo: Reuters

Swagata Yadavar | IndiaSpend New Delhi
Nearly one in five multidrug-resistant (MDR) tuberculosis (TB) patients put on treatment in the public sector were lost to follow-up (LFU). This means that they either did not start treatment or their treatment was disrupted for more than two months.
India has approximately 2.8 million TB patients, a quarter of the world’s total TB cases. Of these 147,000 cases (5.4 per cent) are MDR TB cases–resistant to the first line TB drugs rifampicin and isoniazid. These cases are more difficult and expensive to treat.
While the number of TB cases fell from 2015 to 2016, the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in